Cash-Pay Telemedicine’s Secret: White Labels, Call Centers & Who Really Owns the Risk

In this episode of Telemedicine Talks, Phoebe Gutierrez sits down with healthcare attorney Brigid Maloney to unpack the exploding risks in cash-pay telemedicine, from marketing unapproved peptides and white-label clinician shells to call-center “nursing,” influencer deals, and the coming wave of state enforcement. They explain why low barriers to entry create dangerous naiveté and why everything still lands on the physician’s license. Timestamps: 00:00 – Opening: cash-pay risks, marketing illegal offerings, and low barriers to entry 03:00 – Operational gaps: async vs. sync visits and “compliant on paper” vs. real operations 05:00 – White-label telemedicine, shell companies, and call-center “nursing” 08:00 – Physician follow-up obligations and license accountability 09:00 – Emerging regulations: DEA flexibilities, California PE rules, and state guardrails 12:00 – Enforcement outlook: states vs. federal agencies and medical-board complaints 16:00 – Cost of fixing compliance after the fact vs. building it right 19:00 – Controlled-substance prescribing via telemed: access vs. risk 21:00 – Influencer marketing, lead generation, and FTC exposure 23:00 – Vendor due diligence lessons (including COVID-test lead example) 26:00 – Why volume multiplies fines and the importance of good legal guidance 28:00 – Treating physicians as true partners and the long-term value of clinical relationships 30:00 – Closing, how to reach Brigid and the hosts About the Host: Phoebe Gutierrez – Former state regulator turned telehealth executive, specializing in compliance and sustainable virtual care models. Connect with Phoebe Gutierrez:   / pkgutierrez   phoebe@telemedicinetalks.com (mailto:phoebe@telemedicinetalks.com) #TelemedicineTalks #TelemedicineCompliance #CashPayTelemed #DigitalHealth #PhysicianRisk #WhiteLabelTelemed #TelehealthLaw #MSO #HealthcareCompliance #PhysicianAccountability